Kubota Pharmaceutical Holdings Co., Ltd. restated consolidated and non-consolidated financial results for the fiscal year ended December 31, 2023. The company now reported consolidated operating loss of ¥1,504 million instead of ¥1,394 million, net loss of ¥1,490 million instead of ¥1,379 million, loss attributable to owners of parent of ¥1,490 million instead of ¥1,379 million and basic and diluted loss per share of ¥26.79 instead of ¥24.81.

The company now reported non-consolidated operating loss of ¥145 million instead of ¥146 million, net loss of ¥726 million instead of ¥629 million and basic loss per share of ¥13.06 instead of ¥11.32.